Focal Changes in Diffusivity on Apparent Diffusion Coefficient MR Imaging and Amino Acid Uptake on PET Do Not Colocalize in Nonenhancing Low-Grade Gliomas

被引:21
作者
Rahm, Verena [1 ]
Boxheimer, Larissa [2 ]
Bruehlmeier, Matthias [1 ]
Berberat, Jatta [2 ]
Nitzsche, Egbert U. [1 ,3 ]
Remonda, Luca [2 ]
Roelcke, Ulrich [3 ,4 ,5 ]
机构
[1] Cantonal Hosp, Dept Nucl Med, CH-5001 Aarau, Switzerland
[2] Cantonal Hosp, Dept Neuroradiol, CH-5001 Aarau, Switzerland
[3] Univ Basel, Sch Med, Basel, Switzerland
[4] Cantonal Hosp, Dept Neurol, CH-5001 Aarau, Switzerland
[5] Cantonal Hosp, Brain Tumor Ctr, CH-5001 Aarau, Switzerland
关键词
low-grade glioma; PET; amino acid uptake; MRI; diffusion-weighted imaging; POSITRON-EMISSION-TOMOGRAPHY; EXTRACELLULAR-MATRIX; CELL-DENSITY; MAPS FDMS; C-11-METHIONINE; ASTROCYTOMAS; TUMORS; TRANSPORT; SURVIVAL;
D O I
10.2967/jnumed.113.130732
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Low-grade gliomas (LGGs) may harbor malignant foci, which are characterized by increased tumor cellularity and angiogenesis. We used diffusion-weighted MR imaging (apparent diffusion coefficient [ADC]) and PET with the amino acid O-(2-F-18-fluorethyl)-L-tyrosine (F-18-FET) to search for focal changes of diffusion (ADC) and amino acid uptake and to investigate whether focal changes in these parameters colocalize within LGGs. Methods: We retrospectively selected 18 patients with nonenhancing LGG. All patients had undergone (FFET)-F-18 PET and MR imaging for preoperative evaluation or for therapy monitoring in recurrent or progressive LGG. Region-of-interest analysis was performed to compare F-18-FET uptake and ADC values in areas with focal intratumoralmaximummetabolic activity and diffusion restriction and between tumor and normal brain. F-18-FET uptake was normalized to themean cerebellar uptake (ratio). ADCvalueswere also compared with the F-18-FET uptake on a voxel-by-voxel basis across thewhole tumor. Results: Themean focal maximum (mean +/- SD, 1.69 +/- 0.85) and global F-18-FET uptake in tumors (1.14 +/- 0.41) exceeded that of normal cortex (0.85 +/- 0.09) andcerebrospinal fluid (0.82 +/- 0.20). ADC values in the area with most restricted diffusion (1.07 +/- 0.22 x 10(-3) mm(2)/s) and in the whole tumor (1.38 +/- 0.27 x 10(-3) mm(2)/s) were in the range between normal cortex (0.73 +/- 0.06 x 10(-3) mm(2)/s) and cerebrospinal fluid (2.84 +/- 0.09 x 10(-3)mm(2)/s). F-18-FET uptake did not correlate with corresponding (colocalizing) ADC values, either in the area with focal maximum metabolic activity or in the area with most restricted diffusion or in the whole tumor. Conclusion: There is no congruency between F-18-FET uptake and diffusivity in nonenhancing LGG. Diffusion restriction in these tumorsmost likely represents changes in brain and tumor cell densities as well as alteration ofwater distribution and is probably not directly correlated with the density of tumor cells.
引用
收藏
页码:546 / 550
页数:5
相关论文
共 26 条
  • [1] Barker FG, 1997, CANCER-AM CANCER SOC, V80, P936
  • [2] Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma
    Ellingson, Benjamin M.
    Cloughesy, Timothy F.
    Zaw, Taryar
    Lai, Albert
    Nghiemphu, Phioanh L.
    Harris, Robert
    Lalezari, Shadi
    Wagle, Naveed
    Naeini, Kourosh M.
    Carrillo, Jose
    Liau, Linda M.
    Pope, Whitney B.
    [J]. NEURO-ONCOLOGY, 2012, 14 (03) : 333 - 343
  • [3] Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab
    Ellingson, Benjamin M.
    Cloughesy, Timothy F.
    Lai, Albert
    Nghiemphu, Phioanh L.
    Pope, Whitney B.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (01) : 91 - 101
  • [4] Validation of Functional Diffusion Maps (fDMs) as a Biomarker for Human Glioma Cellularity
    Ellingson, Benjamin M.
    Malkin, Mark G.
    Rand, Scott D.
    Connelly, Jennifer M.
    Quinsey, Carolyn
    LaViolette, Pete S.
    Bedekar, Devyani P.
    Schmainda, Kathleen M.
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2010, 31 (03) : 538 - 548
  • [5] Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence
    Ewelt, Christian
    Floeth, Frank W.
    Felsberg, Joerg
    Steiger, Hans J.
    Sabel, Michael
    Langen, Karl-Josef
    Stoffels, Gabriele
    Stumrner, Walter
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (07) : 541 - 547
  • [6] Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma
    Floeth, Frank W.
    Pauleit, Dirk
    Sabel, Michael
    Stoffels, Gabriele
    Reifenberger, Guido
    Riemenschneider, Markus J.
    Jansen, Paul
    Coenen, Heinz H.
    Steiger, Hans-Jakob
    Langen, Karl-Josef
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 519 - 527
  • [7] CORRELATION OF GLUCOSE CONSUMPTION AND TUMOR-CELL DENSITY IN ASTROCYTOMAS - A STEREOTAXIC PET STUDY
    HERHOLZ, K
    PIETRZYK, U
    VOGES, J
    SCHRODER, R
    HALBER, M
    TREUER, H
    STURM, V
    HEISS, WD
    [J]. JOURNAL OF NEUROSURGERY, 1993, 79 (06) : 853 - 858
  • [8] 11C-methionine PET for differential diagnosis of low-grade gliomas
    Herholz, K
    Hölzer, T
    Bauer, B
    Schröder, R
    Voges, J
    Ernestus, RI
    Mendoza, G
    Weber-Luxenburger, G
    Löttgen, J
    Thiel, A
    Wienhard, K
    Heiss, WD
    [J]. NEUROLOGY, 1998, 50 (05) : 1316 - 1322
  • [9] Apparent Diffusion Coefficient of Glial Neoplasms: Correlation with Fluorodeoxyglucose-Positron-Emission Tomography and Gadolinium-Enhanced MR Imaging
    Holodny, A. I.
    Makeyev, S.
    Beattie, B. J.
    Riad, S.
    Blasberg, R. G.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (06) : 1042 - 1048
  • [10] Methyl-[11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma
    Kracht, LW
    Friese, M
    Herholz, K
    Schroeder, R
    Bauer, B
    Jacobs, A
    Heiss, WD
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (06) : 868 - 873